Proteasome-independent disruption of PML oncogenic domains (PODs), but not covalent modification by SUMO-1, is required for human cytomegalovirus immediate-early protein IE1 to inhibit PML-mediated transcriptional repression

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 10683-10695

  Xu, Y ^a   Ahn, J H ^a   Cheng, M ^a   Aprhys, C M ^a   Chiou, C J ^a   Zong, J ^a   Matunis, M J ^a   Hayward, G S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; IMMEDIATE EARLY PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN IE1; SUMO 1 PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOMEGALOVIRUS; GENE DISRUPTION; GENE LOCUS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METAPHASE CHROMOSOME; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; VIROGENESIS;

ANIMALS; CELL LINE; CYSTEINE ENDOPEPTIDASES; HUMANS; IMMEDIATE-EARLY PROTEINS; MICE; MULTIENZYME COMPLEXES; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; REPRESSOR PROTEINS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL PROTEINS;

EID: 0034755352     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.10683-10695.2001     Document Type: Article

References (85)

1. Epstein-Barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies
2. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML
3. Evaluation and mapping of the DNA binding and oligomerization domains of the IE2 regulatory protein of human cytomegalovirus using yeast one and two hybrid interaction assays
4. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection
5. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
6. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10)
7. Evaluation of interactions of the human cytomegalovirus immediate-early IE2 regulatory protein with small ubiquitin-like modifiers and their conjugation enzyme Ubc9
8. The promyelocytic leukemia gene product (PML) forms stable complexes with the retinoblastoma protein
9. Retinoblastoma protein recruits histone deacetylase to repress transcription
10. SUMO-1 modification of Mdm2 prevents its self- ubiquitination and increases Mdm2 ability to ubiquitinate p53
11. A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection
12. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins
13. Human cytomegalovirus IE2 negatively regulates alpha gene expression via a short target sequence near the transcription start site
14. Human cytomegalovirus IE1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element
15. SUMO-1 modification of IkappaBalpha inhibits NF-κB activation
16. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR
17. Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling
18. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms
19. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms
20. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
21. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant
22. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors
23. Construction of adenovirus vectors through Cre-lox recombination
24. CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein
25. Evolution and function of ubiquitin-like protein-conjugation systems
26. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
27. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2
28. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex
29. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
30. PML is critical for ND10 formation and recruits the PML-interacting protein Daxx to this nuclear structure when modified by SUMO-1
31. Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment
32. A cycloheximide-enhanced protein in cytomegalovirus-infected cells
33. RING finger proteins: Mediators of ubiquitin ligase activity
34. Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins
35. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
36. Identification of three major sentrinization sites in PML
37. In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins
38. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1
39. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus
40. Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes
41. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter
42. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML
43. A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2
44. TAF-like functions of human cytomegalovirus immediate-early proteins
45. Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex
46. Rb interacts with histone deacetylase to repress transcription
47. Retinoblastoma protein represses transcription by recruiting a histone deacetylase
48. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2
49. Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: Mutational analysis of the viral proteins
50. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription
51. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex
52. SUMO-1 modification and its role in targeting the Ran GTPase-activating protein, RanGAP1 to the nuclear pore complex
53. SUMO-nonclassical ubiquitin
54. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β1
55. Cytomegalovirus and their replication
56. Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures
57. c-Jun and p53 activity is modulated by SUMO-1 modification
58. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
59. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
60. The transcriptional coactivators p300 and CBP are histone acetyltransferases
61. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins
62. The IE2 gene products of human cytomegalovirus specifically down-regulate expression from the major immediate-early promoter through a target sequence located near the cap site
63. trans-activation and autoregulation of gene expression by the immeiate-early region 2 gene products of human cytomegalovirus
64. SUMO-1 modification of bovine papillomavirus E1 protein is required for intranuclear accumulation
65. SUMO-1 modification activates the transcriptional response of p53
66. DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
67. Evidence that the UL84 gene product of human cytomegalovirus is essential for promoting oriLyt-dependent DNA replication and formation of replication compartments in cotransfection assays
68. RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor
69. Transcriptional repression by YY1, a human GLI-Kruppel-related protein, and relief of repression by adenovirus E1A protein
70. Promoter-specific trans-activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains
71. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1
72. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter
73. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein
74. Transcriptional repression by the promyelocytic leukemia protein, PML
75. CREB-binding protein and p300 in transcriptional regulation
76. Binding of the human cytomegalovirus 80-kDa immediate-early protein (IE2) to minor groove A/T-rich sequences bounded by CG dinucleotides is regulated by protein oligomerization and phosphorylation
77. Temporal patterns of human cytomegalovirus transcription: Mapping the viral RNAs synthesized at immediate early, early, and late times after infection
78. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product
79. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases
80. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor β1 gene through an Egr-1 binding site
81. Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases
82. Role of SUMO-1-modified PML in nuclear body formation
83. The transcriptional role of PML and the nuclear body
84. Human cytomegalovirus IE1 and IE2 proteins block apoptosis